Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Invested Capital: 2009-2025

Historic Invested Capital for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $2.8 billion.

  • Prestige Consumer Healthcare's Invested Capital rose 1.25% to $2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 1.25%. This contributed to the annual value of $2.8 billion for FY2025, which is 1.67% up from last year.
  • According to the latest figures from Q3 2025, Prestige Consumer Healthcare's Invested Capital is $2.8 billion, which was down 1.06% from $2.8 billion recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Invested Capital ranged from a high of $3.1 billion in Q4 2022 and a low of $2.8 billion during Q2 2024.
  • In the last 3 years, Prestige Consumer Healthcare's Invested Capital had a median value of $2.8 billion in 2023 and averaged $2.8 billion.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Invested Capital grew by 8.08% in 2021 and then fell by 10.00% in 2023.
  • Over the past 5 years, Prestige Consumer Healthcare's Invested Capital (Quarterly) stood at $3.0 billion in 2021, then grew by 2.04% to $3.1 billion in 2022, then dropped by 10.00% to $2.8 billion in 2023, then fell by 0.70% to $2.8 billion in 2024, then grew by 1.25% to $2.8 billion in 2025.
  • Its last three reported values are $2.8 billion in Q3 2025, $2.8 billion for Q2 2025, and $2.8 billion during Q1 2025.